Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New type of vaccine against nicotine addiction developed by TSRI scientists

21.05.2003


Scientists at The Scripps Research Institute (TSRI) have designed a new way to make vaccines against drugs of abuse that could become a valuable tool for treating addiction by helping the body clear the drug from the bloodstream.



The latest vaccine they created using this approach induces the body to clear nicotine.

"These new vaccines greatly suppress the reinforcing aspects of the drug," says principal investigator Kim D. Janda, Ph.D. "Blocking it before it gets to the brain--that’s the key."


The structure and design of the nicotine vaccine are described in an article that will be published in an upcoming issue of the Journal of the American Chemical Society. Research Associate Michael M. Meijler, Ph.D., who is the article’s lead author, synthesized this vaccine under the guidance of Janda, who holds the Ely R. Callaway, Jr. Chair in Chemistry and is an investigator in The Skaggs Institute for Chemical Biology at TSRI.

Having shown the vaccine’s effectiveness in laboratory models, Meijler and Janda have now reformulated the vaccine for investigation for use in human trials. Eventually, this sort of vaccine would be given to people undergoing smoking cessation programs to aid in their recovery.

Many believe that people continue to smoke because tobacco contains nicotine, which is an addictive chemical. Many smoking cessation strategies, in fact, provide cigarette addicts with nicotine from sources other than tobacco--such as patches or gum.

Janda and his laboratory, however, have taken an "immunopharmacotherapy" approach. That is, they have designed a drug that stimulates the immune system to clear the nicotine from the system. They based this work on previous successes Janda had in developing a vaccine for another addictive drug--cocaine--which is currently in clinical trials.

The new idea that they have developed is to take a chemical that resembles nicotine and use it to induce an active immune response. In this immune response, the body produces antibodies against nicotine that can neutralize it in the bloodstream. If a smoker later smokes a cigarette, the antibodies will clear the nicotine from the system before it reaches the brain.

Developing a nicotine vaccine proved difficult. At first, Janda and his colleagues were not able to induce an effective immune response as they had previously with cocaine. Then Janda and Meijler realized that the difference could be that cocaine is a relatively inflexible molecule where nicotine has a flexible axis that allows it to adopt multiple shapes.

Janda and Meijler had been designing a vaccine that was equally flexible, and so they decided to make one that was rigid and resembled only one form of nicotine.

"These [induced] antibodies make a much more focused immune response," says Meijler. In fact, he adds, the vaccine is better because it induced a larger antibody response and the antibodies themselves bound more tightly (with higher affinity) to the nicotine.

Furthermore, adds Janda, "This could be a general method for vaccine development for drugs of abuse--period."

The research article "A New Strategy for Improved Vaccines Using Conformationally Constrained Haptens" is authored by Michael M. Meijler, Masayuki Matsushita, Lawrence J. Altobell, III, Peter Wirsching, and Kim D. Janda and will appear in the June 18, 2003 issue of the Journal of the American Chemical Society. The research was funded by The Skaggs Institute for Research.

Supporting Material: Statistics on Smoking and Public Health
Smoking is a major health problem in the United States, and hundreds of thousands of Americans die each year from smoking-related lung cancer, ischemic heart disease, and chronic airway obstruction.

Although the percentage of U.S. residents who smoke has declined steadily in the United States since the mid-1960s, about 22.8 percent of the total adult population still smokes, according to the U.S. Centers for Disease Control and Prevention (CDC). San Diego and Orange County are two of the five metropolitan areas with the nation’s lowest smoking rates. The San Diego regional rate was 15.2 percent.

Nevertheless, smoking-related cancer is still a great cause for concern in Southern California and in the rest of the nation. In a 2002 report, the CDC estimated that from 1995 to 1999, smoking killed more than 440,000 people in the United States each year and caused more than $150 billion in annual health-related economic losses.



For supporting statistics on tobacco use and related mortality, please see: A 2001 report from the CDC: "Cigarette Smoking in 99 Metropolitan Areas--United States, 2000," MMWR 50(49); December 14, 2001. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5049a3.htm.

A 2002 report from the CDC: "Annual Smoking-Attributable Mortality, Years of Potential Life Lost, and Economic Costs--United States, 19951999," MMWR 51(14) April 12, 2002. http://www.cdc.gov/tobacco/research_data/economics/mmwr5114.highlights.htm.

Jason Bardi | EurekAlert!
Further information:
http://www.scripps.edu/
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5049a3.htm
http://www.cdc.gov/tobacco/research_data/economics/mmwr5114.highlights.htm

More articles from Health and Medicine:

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

nachricht How to turn white fat brown
07.12.2016 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>